A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis

Clinical Therapeutics

Volumn 28, Issue 9, 2006, Pages 1462-1471

  Jackson, James ^a   Fernandes, Ancilla W ^b   Nelson, Winnie ^a  

^a XCENDA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

amoxicillin clavulanate; antibiotic; retrospective claims review; sinusitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT;

ACUTE SINUSITIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CALCULATION; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COVARIANCE; DEMOGRAPHY; DRUG COST; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STATISTICS; TREATMENT FAILURE;

ACUTE DISEASE; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLAVULANIC ACID; COSTS AND COST ANALYSIS; DELAYED-ACTION PREPARATIONS; DIRECT SERVICE COSTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSURANCE CLAIM REVIEW; MALE; RETROSPECTIVE STUDIES; SINUSITIS; TREATMENT OUTCOME;

EID: 33750191355     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.09.018     Document Type: Article

References (32)

1. Berg O., Carenfelt C., Rystedt G., and Anggard A. Occurrence of asymptomatic sinusitis in common cold and other acute ENT infections. Rhinology 24 (1986) 223-225
2. quiz 1224-1225. Gwaltney Jr. J.M. Acute communityacquired sinusitis. Clin Infect Dis 23 (1996) 1209-1223
3. Ray N.F., Baraniuk J.N., Thamer M., et al. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 103 (1999) 408-414
4. Fendrick A.M., Monto A.S., Nightengale B., and Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 163 (2003) 487-494
5. Scott Levin Prescription Audit from Verispan (2002), LLC
6. Physician Drug & Diagnosis Audit (PDDA) and Source Prescription Audit (SPA) from Verispan (2002), LLC
7. (Suppl). Ober N.S. Respiratory tract infections: Consider the total cost of care. Drug Benefit Trends 10 (1998) S23-S29
8. Paladino J.A., Sunderlin J.L., Price C.S., and Schentag J.J. Economic consequences of antimicrobial resistance. Surg Infect (Larchmt) 3 (2002) 259-267
9. Desrosiers M., Frenkiel S., Hamid Q.A., et al. Acute bacterial sinusitis in adults: Management in the primary care setting. J Otolaryngol 31 Suppl 2 (2002) 2S2-2S14
10. Lindbaek M. Acute sinusitis: Guide to selection of antimicrobial therapy. Drugs 64 (2004) 805-819
11. Slavin R.G., Spector S.L., Bernstein I.L., et al., American Academy of Allergy, Asthma and Immunology, American College of Allergy Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of sinusitis: A practice parameter update. J Allergy Clin Immunol 116 Suppl 6 (2005) S13-S47
12. Snow V., Mottur-Pilson C., Hickner J.M., American A.o.F.P., t.A.C.o.P.-A.S.o.I.M., t.C.f.D.C., and a.t.I.D.S.o.A. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 134 (2001) 495-497
13. [published correction appears in Otolaryngol Head Neck Surg. 2004;130:794-796]. Anon, Jacobs M.R., Poole M.D., et al., Sinus and Allergy Health Partnership. Antimicrobial treat ment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 130 Suppl 1 (2004) 1-45
14. The Sanford Guide to Antimicrobial Therapy 2004. 34th ed. (2004), Antimicrobial Therapy, Inc, Hyde Park, NY
15. Tellier G., Brunton S.A., and Nusrat R. Telithromycin for the treatment of acute bacterial maxillary sinusitis: A review of a new antibacterial agent. South Med J 98 (2005) 863-868
16. Brook I. Microbiology and antimicrobial management of sinusitis. J Laryngol Otol 119 (2005) 251-258
17. Jacobs M.R. Extended-release amoxicillin/clavulanate: Optimizing a product for respiratory infections based on pharmacodynamic principles. Expert Rev Anti Infect Ther 3 (2005) 353-360
18. File Jr. T.M., Benninger M.S., and Jacobs M.R. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and communityacquired pneumonia in response to anti microbial-resistance patterns. Clin Lab Med 24 (2004) 531-551
19. Talan D.A., Naber K.G., Palou J., and Elkharrat D. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Int J Antimicrob Agents 23 Suppl 1 (2004) S54-S66
20. Drehobl M.A., De Salvo M.C., Lewis D.E., and Breen J.D. Single-dose azithromycin microspheres vs clarithromycin extended-release for the treatment of mild-to-moderate communityacquired pneumonia in adults. Chest 128 (2005) 2230-2237
21. Augmentin XR [package insert] (2005), GlaxoSmithKline, Research Triangle Park, NC
22. Augmentin [package insert] (2005), GlaxoSmithKline, Research Triangle Park, NC
23. Harnett J., Wilson J., Cheng R., et al. Evaluation of the cost-effectiveness of azithromycin versus amoxicillin, amoxicillin/clavulanate, and clarithromycin for the treatment of acute sinusitis in a large managed care database. Value Health 5 (2002) 258
24. International Classification of Diseases, Ninth Revision, Clinical Modification. 6th ed. (1996), US Dept of Health and Human Services, Public Health Service, Health Care Financing Administration, Washington, DC
25. Halpern M., Schmier J., Richner R., and Togias A. Antimicrobial treatment patterns, resource utilization, and charges associated with acute sinusitis in asthma patients. Am J Health Syst Pharm 57 (2000) 875-881
26. Barron J.J., Grochulski W.D., Merchant S., et al. Treatment costs associated with commonly used branded antibiotics for the management of acute sinusitis, chronic bronchitis and pneumonia. J Appl Res 4 (2004) 24-36
27. Furuno J.P., Metlay J.P., Harnett J.P., et al. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Pharmacoepidemiol Drug Safety 15 (2006) 1-9
28. Piccirillo J.F., Mager D.E., Frisse M.E., et al. Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA 286 (2001) 1849-1856
29. Wu J., Howard D.H., McGowan J.E., et al. Patterns of health care resource utilization after macrolide treatment failure: Results from a large population-base cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia. Clin Ther 26 (2004) 2153-2162
30. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administra tive databases. J Clin Epidemiol 45 (1992) 613-619
31. Piccirillo J.F., Mager D.E., Frisse M.E., et al. Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA 286 (2001) 1849-1856
32. US Surveillance Data-All Ages (2004), Surveillance Data Inc., Plymouth Meeting, Pa. 2001-2004